Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Joe E. who wrote (5234)	8/31/1998 5:25:00 PM
From: Zirdu	Read Replies (1) \| Respond to of 6136

Though I suppose that no one that has followed this thread or AGPH for any length of time wants to hear it, I think this is a good buying opportunity in AGPH. 19 1/4??? No matter what happens with our economy, whether depression, or recession, or no matter what happens in Russia, or Asia, or Japan, I can't see it affecting Agouron's buisness going forward. The absolutely last thing any one will cut back on is purchase of Viracept! So, even in a 1930's style depression or an extreme deflationary scenario, sales of Viracept will just plug along. The only thing of relevance in the overall market for AGPH is long term interest rates. The lower the long term rate, the lower the rate at which we need to discount future AGPH earnings. With long term rates at historic lows, AGPH is a screaming buy. Too bad no one has any money left.